Examining the risks for NSAID-induced gastropathy

S. E. Gabriel, C. Bombardier, L. Jaakkimainen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The medical literature describing the gastrointestinal risks associated with chronic nonsteroidal anti-inflammatory drug (NSAID) therapy is increasing rapidly. In spite of this, clinicians remain uncertain about how to translate this information into clinical practice. Clinical decisions regarding the management of adverse reactions to medications have two components. The first involves risk to the patient, and the second an evaluation of available alternatives for managing that risk. Three research designs have been used to examine this association: ecological studies, case control studies and retrospective cohort studies. Although these designs do not provide the strongest evidence for causation, their results point toward the existence of a risk of serious gastrointestinal reactions of between 1.5 and 10 times greater for NSAID users than for nonusers. The wide variation in results is due to multiple factors, including different research designs, study populations and outcome measures. Several subgroups have been suggested to be at particularly high risk. Risk factors include advanced age, female sex, debilitating rheumatoid disease, previous gastrointestinal disease, ethanol abuse and smoking. Only in the elderly has there been adequate data to support this association. Although the data regarding females is compelling, this may be confounded by the documented increased NSAID use among females. Decision analysis is a useful tool for the quantitative examination of the costs and benefits of management alternatives available for dealing with these risks. Research is needed to identify accurately subgroups of NSAID users at high risk.

Original languageEnglish (US)
Pages (from-to)108-112
Number of pages5
JournalCanadian Journal of Gastroenterology
Volume4
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Anti-Inflammatory Agents
Pharmaceutical Preparations
Drug Users
Research Design
Decision Support Techniques
Gastrointestinal Diseases
Causality
Cost-Benefit Analysis
Case-Control Studies
Cohort Studies
Ethanol
Retrospective Studies
Smoking
Outcome Assessment (Health Care)
Drug Therapy
Research
Population

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gabriel, S. E., Bombardier, C., & Jaakkimainen, L. (1990). Examining the risks for NSAID-induced gastropathy. Canadian Journal of Gastroenterology, 4(3), 108-112.

Examining the risks for NSAID-induced gastropathy. / Gabriel, S. E.; Bombardier, C.; Jaakkimainen, L.

In: Canadian Journal of Gastroenterology, Vol. 4, No. 3, 1990, p. 108-112.

Research output: Contribution to journalArticle

Gabriel, SE, Bombardier, C & Jaakkimainen, L 1990, 'Examining the risks for NSAID-induced gastropathy', Canadian Journal of Gastroenterology, vol. 4, no. 3, pp. 108-112.
Gabriel SE, Bombardier C, Jaakkimainen L. Examining the risks for NSAID-induced gastropathy. Canadian Journal of Gastroenterology. 1990;4(3):108-112.
Gabriel, S. E. ; Bombardier, C. ; Jaakkimainen, L. / Examining the risks for NSAID-induced gastropathy. In: Canadian Journal of Gastroenterology. 1990 ; Vol. 4, No. 3. pp. 108-112.
@article{a4b9afd687884a399fcd7e1b4ae04dbe,
title = "Examining the risks for NSAID-induced gastropathy",
abstract = "The medical literature describing the gastrointestinal risks associated with chronic nonsteroidal anti-inflammatory drug (NSAID) therapy is increasing rapidly. In spite of this, clinicians remain uncertain about how to translate this information into clinical practice. Clinical decisions regarding the management of adverse reactions to medications have two components. The first involves risk to the patient, and the second an evaluation of available alternatives for managing that risk. Three research designs have been used to examine this association: ecological studies, case control studies and retrospective cohort studies. Although these designs do not provide the strongest evidence for causation, their results point toward the existence of a risk of serious gastrointestinal reactions of between 1.5 and 10 times greater for NSAID users than for nonusers. The wide variation in results is due to multiple factors, including different research designs, study populations and outcome measures. Several subgroups have been suggested to be at particularly high risk. Risk factors include advanced age, female sex, debilitating rheumatoid disease, previous gastrointestinal disease, ethanol abuse and smoking. Only in the elderly has there been adequate data to support this association. Although the data regarding females is compelling, this may be confounded by the documented increased NSAID use among females. Decision analysis is a useful tool for the quantitative examination of the costs and benefits of management alternatives available for dealing with these risks. Research is needed to identify accurately subgroups of NSAID users at high risk.",
author = "Gabriel, {S. E.} and C. Bombardier and L. Jaakkimainen",
year = "1990",
language = "English (US)",
volume = "4",
pages = "108--112",
journal = "Canadian Journal of Gastroenterology and Hepatology",
issn = "2291-2789",
publisher = "Pulsus Group Inc.",
number = "3",

}

TY - JOUR

T1 - Examining the risks for NSAID-induced gastropathy

AU - Gabriel, S. E.

AU - Bombardier, C.

AU - Jaakkimainen, L.

PY - 1990

Y1 - 1990

N2 - The medical literature describing the gastrointestinal risks associated with chronic nonsteroidal anti-inflammatory drug (NSAID) therapy is increasing rapidly. In spite of this, clinicians remain uncertain about how to translate this information into clinical practice. Clinical decisions regarding the management of adverse reactions to medications have two components. The first involves risk to the patient, and the second an evaluation of available alternatives for managing that risk. Three research designs have been used to examine this association: ecological studies, case control studies and retrospective cohort studies. Although these designs do not provide the strongest evidence for causation, their results point toward the existence of a risk of serious gastrointestinal reactions of between 1.5 and 10 times greater for NSAID users than for nonusers. The wide variation in results is due to multiple factors, including different research designs, study populations and outcome measures. Several subgroups have been suggested to be at particularly high risk. Risk factors include advanced age, female sex, debilitating rheumatoid disease, previous gastrointestinal disease, ethanol abuse and smoking. Only in the elderly has there been adequate data to support this association. Although the data regarding females is compelling, this may be confounded by the documented increased NSAID use among females. Decision analysis is a useful tool for the quantitative examination of the costs and benefits of management alternatives available for dealing with these risks. Research is needed to identify accurately subgroups of NSAID users at high risk.

AB - The medical literature describing the gastrointestinal risks associated with chronic nonsteroidal anti-inflammatory drug (NSAID) therapy is increasing rapidly. In spite of this, clinicians remain uncertain about how to translate this information into clinical practice. Clinical decisions regarding the management of adverse reactions to medications have two components. The first involves risk to the patient, and the second an evaluation of available alternatives for managing that risk. Three research designs have been used to examine this association: ecological studies, case control studies and retrospective cohort studies. Although these designs do not provide the strongest evidence for causation, their results point toward the existence of a risk of serious gastrointestinal reactions of between 1.5 and 10 times greater for NSAID users than for nonusers. The wide variation in results is due to multiple factors, including different research designs, study populations and outcome measures. Several subgroups have been suggested to be at particularly high risk. Risk factors include advanced age, female sex, debilitating rheumatoid disease, previous gastrointestinal disease, ethanol abuse and smoking. Only in the elderly has there been adequate data to support this association. Although the data regarding females is compelling, this may be confounded by the documented increased NSAID use among females. Decision analysis is a useful tool for the quantitative examination of the costs and benefits of management alternatives available for dealing with these risks. Research is needed to identify accurately subgroups of NSAID users at high risk.

UR - http://www.scopus.com/inward/record.url?scp=0025141148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025141148&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025141148

VL - 4

SP - 108

EP - 112

JO - Canadian Journal of Gastroenterology and Hepatology

JF - Canadian Journal of Gastroenterology and Hepatology

SN - 2291-2789

IS - 3

ER -